Affordable Access

deepdyve-link
Publisher Website

Placebo-controlled trial to determine the effectiveness of a urea/lactic acid-based topical keratolytic agent for prevention of capecitabine-induced hand-foot syndrome: North Central Cancer Treatment Group Study N05C5.

Authors
  • Wolf, Sherry L
  • Qin, Rui
  • Menon, Smitha P
  • Rowland, Kendrith M Jr
  • Thomas, Sachdev
  • Delaune, Robert
  • Christian, Diana
  • Pajon, Eduardo R Jr
  • Satele, Daniel V
  • Berenberg, Jeffrey L
  • Loprinzi, Charles L
Type
Published Article
Journal
Journal of Clinical Oncology
Publisher
American Society of Clinical Oncology
Publication Date
Dec 10, 2010
Volume
28
Issue
35
Pages
5182–5187
Identifiers
DOI: 10.1200/JCO.2010.31.1431
PMID: 21060036
Source
Medline
License
Unknown

Abstract

These data do not support the efficacy of a ULABTKA cream for preventing HFS symptoms in patients receiving capecitabine.

Report this publication

Statistics

Seen <100 times